{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:00:44Z","timestamp":1791644444425,"version":"4.3.4"},"reference-count":313,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["17x(3)\/Adhoc\/33\/2022-ITR"],"award-info":[{"award-number":["17x(3)\/Adhoc\/33\/2022-ITR"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EM\/Dev\/SG\/75\/0782\/2023"],"award-info":[{"award-number":["EM\/Dev\/SG\/75\/0782\/2023"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"India Ministry of Science &amp; Technology Department of Science and Technology","doi-asserted-by":"publisher","award":["220005"],"award-info":[{"award-number":["220005"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Government of India Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP43065\/2021"],"award-info":[{"award-number":["BT\/INF\/22\/SP43065\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.arr.2025.102921","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T23:30:28Z","timestamp":1760657428000},"page":"102921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["From pathogenesis to precision medicine: Targeting immune imbalance in multiple sclerosis"],"prefix":"10.1016","volume":"113","author":[{"given":"Anjana","family":"Pithakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaik","family":"Basha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna Ramakrishna","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9873-3445","authenticated-orcid":false,"given":"Krishna Kishore","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2025.102921_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12883-024-03815-9","article-title":"Lifetime exposure to smoking and substance abuse May be associated with late-onset multiple sclerosis: a population-based case-control study","volume":"24","author":"Abbasi Kasbi","year":"2024","journal-title":"BMC Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33158-8","article-title":"Serum GFAP as a biomarker for disease severity in multiple sclerosis","volume":"8","author":"Abdelhak","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/acn3.51969","article-title":"Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis","volume":"11","author":"Abdelhak","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2022.111339","article-title":"An investigation of the effect of brain atrophy on brain injury in multiple sclerosis","volume":"557","author":"Abdi","year":"2023","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.arr.2025.102921_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/pmrj.13121","article-title":"The association of multiple sclerosis, traumatic brain injury, and spinal cord injury to acute and long <scp>COVID<\/scp> -19 outcomes","volume":"16","author":"Abramoff","year":"2024","journal-title":"PMR"},{"key":"10.1016\/j.arr.2025.102921_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40001-024-01700-2","article-title":"Role of fenofibrate in multiple sclerosis","volume":"29","author":"Abulaban","year":"2024","journal-title":"Eur. J. Med Res"},{"key":"10.1016\/j.arr.2025.102921_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.70067","article-title":"The possible role of metformin and fibroblast growth Factor-21 in multiple sclerosis neuropathology: birds of a feather flock together","volume":"61","author":"Abulaban","year":"2025","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2025.102921_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111333","article-title":"Role of liver x receptor in multiple sclerosis: a long furtive life behind a barrier","volume":"224","author":"Abulaban","year":"2025","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.arr.2025.102921_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/17590914231198980","article-title":"An association of Chitinase-3 Like-Protein-1 with neuronal deterioration in multiple sclerosis","volume":"15","author":"Ahmad","year":"2023","journal-title":"ASN Neuro"},{"key":"10.1016\/j.arr.2025.102921_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151683","article-title":"Accumulation of meningeal lymphocytes correlates with White matter lesion activity in progressive multiple sclerosis","volume":"7","author":"Ahmed","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.arr.2025.102921_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2025-336063","article-title":"Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis","author":"Ahola","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry jnnp2025336063"},{"key":"10.1016\/j.arr.2025.102921_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/jnnp-2022-330123","article-title":"Insufficient sleep during adolescence and risk of multiple sclerosis: results from a Swedish case-control study","volume":"94","author":"\u00c5kerstedt","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102921_bib13","doi-asserted-by":"crossref","first-page":"13759","DOI":"10.3390\/ijms232213759","article-title":"Acute effects of ocrelizumab infusion in multiple sclerosis patients","volume":"23","author":"Akg\u00fcn","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jbmt.2024.06.013","article-title":"Effects of closed kinetic chain exercises on balance and gait in people with multiple sclerosis: a randomized controlled trial","volume":"40","author":"Alashram","year":"2024","journal-title":"J. Bodyw. Mov. Ther."},{"key":"10.1016\/j.arr.2025.102921_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00601","article-title":"Progressive multiple sclerosis: evaluating current therapies and exploring future treatment strategies","author":"Albelo-Mart\u00ednez","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2025.102921_bib16","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1007\/s00415-024-12277-5","article-title":"Thalamic nuclei volume partially mediates the effects of aerobic capacity on fatigue in people with multiple sclerosis","volume":"271","author":"Albergoni","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.138036","article-title":"Altered miR-10a gene expression in peripheral blood mononuclear cells correlates with frequency of t regulatory cells and cytokine profile in multiple sclerosis patients","volume":"844","author":"Alipour","year":"2025","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2025.102921_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2174\/1874467214666210902115650","article-title":"Impact of sitagliptin on Non-diabetic Covid-19 patients","volume":"15","author":"Al-kuraishy","year":"2022","journal-title":"Curr. Mol. Pharm."},{"key":"10.1016\/j.arr.2025.102921_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/15548627.2023.2259281","article-title":"The beneficial role of autophagy in multiple sclerosis: yes or no?","volume":"20","author":"Al-kuraishy","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.arr.2025.102921_bib20","first-page":"30","article-title":"The compelling role of Brain-Derived neurotrophic factor signaling in multiple sclerosis: role of <scp>BDNF<\/scp> activators","author":"Al-kuraishy","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2025.102921_bib21","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10787-023-01240-x","article-title":"The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects","volume":"31","author":"Al-Kuraishy","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.arr.2025.102921_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113048","article-title":"HHV-6 and EBV reactivation in relapsing remitting multiple sclerosis: disability, progression, and inflammation links","volume":"28","author":"Almulla","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.arr.2025.102921_bib23","first-page":"730","article-title":"Environmental and familial risk factors for multiple sclerosis: insights from a Saudi Arabian cohort","volume":"61","author":"Alruwaili","year":"2025","journal-title":"Medicine"},{"key":"10.1016\/j.arr.2025.102921_bib24","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1007\/s11064-023-03981-1","article-title":"Pathogenic role of fibrinogen in the neuropathology of multiple sclerosis: a tale of sorrows and fears","volume":"48","author":"Alruwaili","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2025.102921_bib25","first-page":"1","article-title":"The relationship between biological sex, cognitive reserve, and cognition in multiple sclerosis","author":"Altieri","year":"2025","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.arr.2025.102921_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103298","article-title":"Melatonin synergistically potentiates the effect of methylprednisolone on reducing neuroinflammation in the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"148","author":"\u00c1lvarez-L\u00f3pez","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.arr.2025.102921_bib27","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.3390\/jcm11092405","article-title":"The impact of resistance training program on static balance in multiple sclerosis population: a randomized controlled trial study","volume":"11","author":"Andreu-Caravaca","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.arr.2025.102921_bib28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00234-023-03174-1","article-title":"Distinct hemodynamic and functional connectivity features of fatigue in clinically isolated syndrome and multiple sclerosis: accounting for the confounding effect of concurrent depression symptoms","volume":"65","author":"Antypa","year":"2023","journal-title":"Neuroradiology"},{"key":"10.1016\/j.arr.2025.102921_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105445","article-title":"Association between multiple sclerosis and urinary levels of toxic metals and organophosphates: a cross-sectional study in Israel","volume":"83","author":"Armon-Omer","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46047-6","article-title":"The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial","volume":"13","author":"Asghari","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109870","article-title":"B cell activating factor levels are linked to distinct b cell markers in multiple sclerosis and following b cell depletion and repopulation","volume":"258","author":"Asplund H\u00f6gelin","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67934-2","article-title":"Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity","volume":"10","author":"Ayrignac","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib33","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.3390\/ijms26094160","article-title":"Implications of chitinase 3-like 1 protein in the pathogenesis of multiple sclerosis in autopsied brains and a murine model","volume":"26","author":"Bando","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.837452","article-title":"Diffusion tensor imaging revealed microstructural changes in Normal-Appearing White matter regions in Relapsing\u2013Remitting multiple sclerosis","volume":"16","author":"Bao","year":"2022","journal-title":"Front Neurosci."},{"key":"10.1016\/j.arr.2025.102921_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104662","article-title":"Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials","volume":"93","author":"Bar-Or","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2025.102921_bib36","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200052","article-title":"Serum GFAP and NfL levels differentiate subsequent progression and disease activity in patients with progressive multiple sclerosis","volume":"10","author":"Barro","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102017","article-title":"A comprehensive review of protein misfolding disorders, underlying mechanism, clinical diagnosis, and therapeutic strategies","volume":"90","author":"Basha","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102921_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143725","article-title":"Assessing amyloid fibrils and amorphous aggregates: a review","volume":"311","author":"Basha","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2025.102921_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00210-022-02325-0","article-title":"Commiphora myrrh: a phytochemical and pharmacological update","volume":"396","author":"Batiha","year":"2023","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.arr.2025.102921_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221146836","article-title":"Disease-modifying therapies for relapsing\/active secondary progressive multiple sclerosis \u2013 a review of population-specific evidence from randomized clinical trials","volume":"16","author":"Bayas","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib41","article-title":"Identifying the White matter pathways involved in multiple sclerosis-related tremor using diffusion tensor imaging","volume":"9","author":"Bayoumi","year":"2023","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.arr.2025.102921_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106377","article-title":"Kappa-free light chain as a practical alternative to oligoclonal bands in the diagnosis of multiple sclerosis","volume":"97","author":"Beckmann","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161849","article-title":"The value of interferon \u03b2 in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review","volume":"14","author":"Bellucci","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib44","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200016","article-title":"Patients with severe multiple sclerosis exhibit functionally altered CD8 + regulatory t cells","volume":"9","author":"Benallegue","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib45","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001005","article-title":"Kappa-Free light chains in CSF predict early multiple sclerosis disease activity","volume":"8","author":"Berek","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13073-021-00925-8","article-title":"Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis","volume":"13","author":"Bernardo-Faura","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.arr.2025.102921_bib47","doi-asserted-by":"crossref","DOI":"10.25259\/SNI_1114_2024","article-title":"Immunoexcitoxicity as the possible major pathophysiology behind multiple sclerosis and other autoimmune disorders","volume":"16","author":"Blaylock","year":"2025","journal-title":"Surg. Neurol. Int"},{"key":"10.1016\/j.arr.2025.102921_bib48","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3390\/jcm10091998","article-title":"JC virus seroprevalence and JCVAb index in polish multiple sclerosis patients treated with immunomodulating or immunosuppressive therapies","volume":"10","author":"Bonek","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.arr.2025.102921_bib49","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200167","article-title":"Increasing neurofilament and glial fibrillary acidic protein after treatment discontinuation predicts multiple sclerosis disease activity","volume":"10","author":"Bose","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib50","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(24)00354-5","article-title":"Comparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trial","volume":"23","author":"Braley","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib51","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208954","article-title":"c-Met: a new signature of Pro-inflammatory CD4+ t cells in multiple sclerosis (P5-1.010)","volume":"104","author":"Breville","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102921_bib52","doi-asserted-by":"crossref","DOI":"10.1177\/17562864251342855","article-title":"Cladribine tablets in the new multiple sclerosis era","volume":"18","author":"Buttari","year":"2025","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jon.12934","article-title":"Machine learning to investigate superficial White matter integrity in early multiple sclerosis","volume":"32","author":"Buyukturkoglu","year":"2022","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.arr.2025.102921_bib54","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00415-022-11535-8","article-title":"Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis","volume":"270","author":"Cagol","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/ene.15588","article-title":"Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis","volume":"30","author":"Camara-Lemarroy","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib56","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/biomedicines13020440","article-title":"The diagnostic utility of oligoclonal bands in multiple sclerosis: a Time-Course analysis","volume":"13","author":"Candeloro","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2025.102921_bib57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/cells12030439","article-title":"People with primary progressive multiple sclerosis have a lower number of central memory t cells and HLA-DR+ tregs","volume":"12","author":"Canto-Gomes","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.arr.2025.102921_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.156866","article-title":"Immune mechanisms in multiple sclerosis: CD3 levels on CD28+ CD4+ t cells link antibody responses to human herpesvirus 6","volume":"187","author":"Cao","year":"2025","journal-title":"Cytokine"},{"key":"10.1016\/j.arr.2025.102921_bib59","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1177\/1352458520981910","article-title":"Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability","volume":"27","author":"Capuano","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.arr.2025.102921_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104542","article-title":"Specific alterations in NKG2D+ t lymphocytes in relapsing-remitting and progressive multiple sclerosis patients","volume":"71","author":"Carmena Moratalla","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib61","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.3390\/s24227284","article-title":"Walk longer! using wearable inertial sensors to uncover which gait aspects should be treated to increase walking endurance in people with multiple sclerosis","volume":"24","author":"Carpinella","year":"2024","journal-title":"Sensors"},{"key":"10.1016\/j.arr.2025.102921_bib62","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s13311-021-01104-8","article-title":"Predictors of ocrelizumab effectiveness in patients with multiple sclerosis","volume":"18","author":"Cellerino","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2025.102921_bib63","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005118","article-title":"Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis","volume":"90","author":"Chataway","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102921_bib64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1474-4422(24)00027-9","article-title":"Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges","volume":"23","author":"Chataway","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2023.102843","article-title":"Conversion predictors of clinically isolated syndrome to multiple sclerosis in Mexican patients: a prospective study","volume":"54","author":"Chavarria","year":"2023","journal-title":"Arch. Med Res"},{"key":"10.1016\/j.arr.2025.102921_bib66","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s13311-023-01415-y","article-title":"Effectiveness of ocrelizumab in primary progressive multiple sclerosis: a multicenter, retrospective, Real-world study (OPPORTUNITY)","volume":"20","author":"Chisari","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2025.102921_bib67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40259-020-00462-7","article-title":"Administration of CD4+CD25highCD127\u2212FoxP3+ regulatory t cells for Relapsing-Remitting multiple sclerosis: a phase 1 study","volume":"35","author":"Chwojnicki","year":"2021","journal-title":"BioDrugs"},{"key":"10.1016\/j.arr.2025.102921_bib68","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/jmri.29046","article-title":"Global and regional deep learning models for multiple sclerosis stratification from MRI","volume":"60","author":"Coll","year":"2024","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.arr.2025.102921_bib69","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41582-024-01006-1","article-title":"Assessing disease progression and treatment response in progressive multiple sclerosis","volume":"20","author":"Comi","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1431380","article-title":"Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis","volume":"15","author":"Constantinescu","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.arr.2025.102921_bib71","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.msard.2019.08.006","article-title":"Secukinumab May be a valid treatment option in patients with CNS demyelination and concurrent ankylosing spondylitis: report of two clinical cases","volume":"35","author":"Cortese","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib72","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40263-024-01066-3","article-title":"Real-World retrospective analysis of alemtuzumab outcomes in Relapsing-Remitting multiple sclerosis: the LEMCAM study","volume":"38","author":"Costa-Frossard Fran\u00e7a","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arr.2025.102921_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15511-0","article-title":"High B-value diffusion tensor imaging for early detection of hippocampal microstructural alteration in a mouse model of multiple sclerosis","volume":"12","author":"Cromb\u00e9","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib74","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1756285612461165","article-title":"Rituximab combination therapy in relapsing multiple sclerosis","volume":"5","author":"Cross","year":"2012","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578531","article-title":"MicroRNA signatures of CD4+ t cell subsets in healthy and multiple sclerosis subjects determined by small RNA-sequencing","volume":"401","author":"Culina","year":"2025","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.arr.2025.102921_bib76","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3390\/ijms23031664","article-title":"Differential expression of serum extracellular vesicle miRNAs in multiple sclerosis: Disease-Stage specificity and relevance to pathophysiology","volume":"23","author":"Cuomo-Haymour","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib77","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.3390\/ijms25147759","article-title":"An overview of multiple sclerosis in vitro models","volume":"25","author":"Czpakowska","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib78","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/ph17020150","article-title":"NK cell levels correlate with disease activity in patients with multiple sclerosis on Ocrelizumab\/Rituximab therapy","volume":"17","author":"Dal Bello","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.arr.2025.102921_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae292","article-title":"Understanding the mechanisms of fatigue in multiple sclerosis: linking interoception, metacognition and White matter dysconnectivity","volume":"6","author":"Danciut","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2025.102921_bib80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41582-020-00446-9","article-title":"Facing the urgency of therapies for progressive MS \u2014 a progressive MS alliance proposal","volume":"17","author":"Dangond","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib81","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1038\/s41598-020-64432-3","article-title":"Replication analysis of variants associated with multiple sclerosis risk","volume":"10","author":"Dashti","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib82","doi-asserted-by":"crossref","DOI":"10.1242\/bio.059845","article-title":"Cerebral organoids in primary progressive multiple sclerosis reveal stem cell and oligodendrocyte differentiation defect","volume":"12","author":"Daviaud","year":"2023","journal-title":"Biol. Open"},{"key":"10.1016\/j.arr.2025.102921_bib83","doi-asserted-by":"crossref","unstructured":"Daviaud, N., Mehta, T., Holzman, W., McDermott, A., Sadiq, S.A., 2025. Impaired Myelination in Multiple Sclerosis Organoids: p21 Links Oligodendrocyte Dysfunction to Disease Subtype. https:\/\/doi.org\/10.1101\/2025.01.08.631924.","DOI":"10.1101\/2025.01.08.631924"},{"key":"10.1016\/j.arr.2025.102921_bib84","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/13524585241311212","article-title":"Neurofilament heavy chain in secondary progressive multiple sclerosis","volume":"31","author":"De Angelis","year":"2025","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.arr.2025.102921_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1385231","article-title":"Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis","volume":"15","author":"Dekeyser","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib86","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001154","article-title":"Neurofilament light chain levels in multiple sclerosis correlate with lesions containing foamy macrophages and with acute axonal damage","volume":"9","author":"van den Bosch","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib87","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1007\/s00259-022-05770-4","article-title":"Quantitative assessment of myelin density using [11C]MeDAS PET in patients with multiple sclerosis: a first-in-human study","volume":"49","author":"van der Weijden","year":"2022","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.arr.2025.102921_bib88","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00234-024-03366-3","article-title":"Enlargement of the choroid plexus in pediatric multiple sclerosis","volume":"66","author":"de Deus Vieira","year":"2024","journal-title":"Neuroradiology"},{"key":"10.1016\/j.arr.2025.102921_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102566","article-title":"Molecular mechanisms of neurofilament alterations and its application in assessing neurodegenerative disorders","volume":"102","author":"Devarakonda","year":"2024","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.arr.2025.102921_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167303","article-title":"Follicular CD8+ t cells promote immunoglobulin production and demyelination in multiple sclerosis and a murine model","volume":"1870","author":"Ding","year":"2024","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.arr.2025.102921_bib91","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/14728222.2023.2236301","article-title":"An appraisal of emerging therapeutic targets for multiple sclerosis derived from current preclinical models","volume":"27","author":"Dixit","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.arr.2025.102921_bib92","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/WNO.0000000000001326","article-title":"Optical coherence tomography is associated with cognitive impairment in multiple sclerosis","volume":"42","author":"Dreyer-Alster","year":"2022","journal-title":"J. NeuroOphthalmol."},{"key":"10.1016\/j.arr.2025.102921_bib93","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/acn3.52009","article-title":"<scp>CD11c<\/scp> + b cells in relapsing\u2013remitting multiple sclerosis and effects of <scp>anti-CD20<\/scp> therapy","volume":"11","author":"El Mahdaoui","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib94","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s40478-019-0855-7","article-title":"Molecular signature of different lesion types in the brain White matter of patients with progressive multiple sclerosis","volume":"7","author":"Elkjaer","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2025.102921_bib95","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/brain\/awz212","article-title":"Chronic White matter lesion activity predicts clinical progression in primary progressive multiple sclerosis","volume":"142","author":"Elliott","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.102921_bib96","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s43055-024-01188-0","article-title":"Differentiating multiple sclerosis from cerebral small vessel disease using diffusion tensor imaging and magnetic resonance spectroscopy on normally appearing thalami","volume":"55","author":"elsalam","year":"2024","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"key":"10.1016\/j.arr.2025.102921_bib97","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70058","article-title":"Smoking and obesity interact to adversely affect disease progression and cognitive performance in multiple sclerosis","volume":"32","author":"Eva","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib98","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2174\/0118715230293847240314073359","article-title":"Immunoregulatory effects of the active form of vitamin d (Calcitriol), individually and in combination with curcumin, on peripheral blood mononuclear cells (PBMCs) of multiple sclerosis (MS) patients","volume":"23","author":"Fasihi","year":"2024","journal-title":"Antiinflamm Antiallergy Agents Med Chem."},{"key":"10.1016\/j.arr.2025.102921_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.882426","article-title":"Eating hubs in multiple sclerosis: exploring the relationship between Mediterranean diet and disability status in Italy","volume":"9","author":"Felicetti","year":"2022","journal-title":"Front Nutr."},{"key":"10.1016\/j.arr.2025.102921_bib100","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2023-332251","article-title":"Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis","author":"Fissolo","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry jnnp2023332251"},{"key":"10.1016\/j.arr.2025.102921_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103266","article-title":"Mutations in the john cunningham virus VP1 gene could predispose to the development of progressive multifocal leukoencephalopathy in multiple sclerosis patients undergoing treatment with natalizumab","volume":"56","author":"Flores","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578328","article-title":"Novel biomarkers and interferon signature in secondary progressive multiple sclerosis","volume":"389","author":"Fogel","year":"2024","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.arr.2025.102921_bib103","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178949","article-title":"Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis","volume":"134","author":"Fondelli","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.arr.2025.102921_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102330","article-title":"Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone","volume":"44","author":"Foo","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106400","article-title":"Early extended interval dosing of rituximab in multiple sclerosis: a comparative cohort study on efficacy and safety","volume":"97","author":"Fossum","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib106","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200606","article-title":"Long-term treatment with ponesimod in Relapsing-Remitting multiple sclerosis","volume":"99","author":"Freedman","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102921_bib107","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/cells9102290","article-title":"Re-Examining the role of TNF in MS pathogenesis and therapy","volume":"9","author":"Fresegna","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.arr.2025.102921_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106586","article-title":"Verona validation of the DAAE score, a tool for estimating risk of clinical disease progression in people with multiple sclerosis","volume":"101","author":"Fuchs","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib109","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.3390\/biomedicines12122737","article-title":"Analysis of immunological memory for john cunningham virus in a Mexican population of patients with multiple sclerosis under treatment","volume":"12","author":"Garc\u00eda","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2025.102921_bib110","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1177\/13524585221078825","article-title":"Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: results from ASCLEPIOS I and II","volume":"28","author":"G\u00e4rtner","year":"2022","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.arr.2025.102921_bib111","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.3390\/ijms25137399","article-title":"Cytokine profiling in cerebrospinal fluid of patients with newly diagnosed Relapsing-Remitting multiple sclerosis (RRMS): associations between inflammatory biomarkers and disease activity","volume":"25","author":"G\u0119bka-K\u0119pi\u0144ska","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib112","doi-asserted-by":"crossref","first-page":"32","DOI":"10.34172\/ajpr.2022.1065","article-title":"Comparison of the total side effects of injectable Disease-Modifying drugs for the First-line treatment of Relapsing-Remitting multiple sclerosis","volume":"3","author":"Ghiasian","year":"2022","journal-title":"Avicenna J. Pharm. Res."},{"key":"10.1016\/j.arr.2025.102921_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00616","article-title":"SeXX matters in multiple sclerosis","volume":"11","author":"Gilli","year":"2020","journal-title":"Front Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib114","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00330-023-10173-6","article-title":"Longitudinal analysis of new multiple sclerosis lesions with magnetization transfer and diffusion tensor imaging","volume":"34","author":"Gloor","year":"2023","journal-title":"Eur. Radio."},{"key":"10.1016\/j.arr.2025.102921_bib115","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1007\/s10072-021-05052-1","article-title":"Cyclophosphamide treatment in active multiple sclerosis","volume":"42","author":"G\u00f3mez-Figueroa","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib116","doi-asserted-by":"crossref","first-page":"14594","DOI":"10.3390\/ijms241914594","article-title":"Genetic variant HLA-DRB1*0403 and therapeutic response to Disease-Modifying therapies in multiple sclerosis: a Case-Control study","volume":"24","author":"Gomez-Gaitan","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105749","article-title":"Impact of sex on clinical outcome in early multiple sclerosis","volume":"88","author":"Gottwald","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228883","article-title":"Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides","volume":"15","author":"Graner","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2025.102921_bib119","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","article-title":"Ageing and multiple sclerosis","volume":"22","author":"Graves","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2022.123304","article-title":"Monitoring autoimmune diseases by bioelectrochemical detection of autoantibodies. Application to the determination of anti-myelin basic protein autoantibodies in serum of multiple sclerosis patients","volume":"243","author":"Guerrero","year":"2022","journal-title":"Talanta"},{"key":"10.1016\/j.arr.2025.102921_bib121","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/bios12080610","article-title":"Development of an electrochemical CCL5 chemokine immunoplatform for rapid diagnosis of multiple sclerosis","volume":"12","author":"Guerrero","year":"2022","journal-title":"Biosens. (Basel)"},{"key":"10.1016\/j.arr.2025.102921_bib122","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2967\/jnumed.120.259325","article-title":"Longitudinal imaging of t cells and inflammatory demyelination in a preclinical model of multiple sclerosis using 18 F-FAraG PET and MRI","volume":"63","author":"Guglielmetti","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2025.102921_bib123","article-title":"Effects of lycium barbarum polysaccharide on the activation of pathogenic CD4+ t cells in a mouse model of multiple sclerosis","author":"Guo","year":"2025","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.arr.2025.102921_bib124","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.arr.2025.102921_bib125","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.mucimm.2023.05.006","article-title":"Tr1 cell-mediated protection against autoimmune disease by intranasal administration of a fusion protein targeting cDC1 cells","volume":"16","author":"Hansson","year":"2023","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105697","article-title":"A novel combination approach to effectively reduce inflammation and neurodegeneration in multiple sclerosis models","volume":"175","author":"Haque","year":"2024","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.arr.2025.102921_bib127","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/NNR.0000000000000656","article-title":"Longitudinal effects of sex, aging, and multiple sclerosis diagnosis on function","volume":"72","author":"Harrison","year":"2023","journal-title":"Nurs. Res"},{"key":"10.1016\/j.arr.2025.102921_bib128","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13102-025-01146-x","article-title":"Internet-based exercise and physical activity promotion for persons with multiple sclerosis: a randomized controlled trial","volume":"17","author":"Hartung","year":"2025","journal-title":"BMC Sports Sci. Med Rehabil."},{"key":"10.1016\/j.arr.2025.102921_bib129","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200094","article-title":"Association of higher ocrelizumab exposure with reduced disability progression in multiple sclerosis","volume":"10","author":"Hauser","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1148\/radiol.210614","article-title":"Extensive brain pathologic alterations detected with 7.0-T MR spectroscopic imaging associated with disability in multiple sclerosis","volume":"303","author":"Heckova","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.arr.2025.102921_bib131","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2025-336738","article-title":"Beneficial impact of physical activity on multiple sclerosis disability progression","author":"Hedstr\u00f6m","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry jnnp2025336738"},{"key":"10.1016\/j.arr.2025.102921_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104573","article-title":"Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity\u2014a cohort study","volume":"91","author":"Hegen","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2025.102921_bib133","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68715-x","article-title":"Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models","volume":"14","author":"Hendek","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104458","article-title":"Dimethyl fumarate treatment of primary progressive multiple sclerosis: results of an open-label extension study","volume":"70","author":"H\u00f8jsgaard Chow","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib135","article-title":"Clinical and radiologic outcomes in two patients with multiple sclerosis treated with tocilizumab for COVID-19","volume":"2","author":"Holroyd","year":"2022","journal-title":"Neuroimmunol. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib136","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12984-020-00798-9","article-title":"Inertial sensor-based gait parameters reflect patient-reported fatigue in multiple sclerosis","volume":"17","author":"Ibrahim","year":"2020","journal-title":"J. Neuroeng. Rehabil."},{"key":"10.1016\/j.arr.2025.102921_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114579","article-title":"Altered t cell development in an animal model of multiple sclerosis","volume":"371","author":"Jiang","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib138","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/biom14101266","article-title":"Antioxidant therapies in the treatment of multiple sclerosis","volume":"14","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2025.102921_bib139","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1408224","article-title":"Smartphone tests quantify lower extremities dysfunction in multiple sclerosis","volume":"15","author":"Jin","year":"2024","journal-title":"Front Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2024-000670","article-title":"Brain reserve and physical disability in secondary progressive multiple sclerosis","volume":"6","author":"John","year":"2024","journal-title":"BMJ Neurol. Open"},{"key":"10.1016\/j.arr.2025.102921_bib141","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/05704928.2025.2477237","article-title":"Fluorescence in probing the biochemical and conformational changes in non-enzymatically glycated proteins","volume":"60","author":"K","year":"2025","journal-title":"Appl. Spectrosc. Rev."},{"key":"10.1016\/j.arr.2025.102921_bib142","doi-asserted-by":"crossref","DOI":"10.5603\/PJNNS.a2023.0035","article-title":"Prevalence and prognostic value of prodromal symptoms in relapsing-remitting multiple sclerosis","author":"Kania","year":"2023","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.arr.2025.102921_bib143","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1474-4422(14)70028-6","article-title":"Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial","volume":"13","author":"Kappos","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib144","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2025.102921_bib145","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00415-023-11943-4","article-title":"Ocrelizumab exposure in relapsing\u2013remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension","volume":"271","author":"Kappos","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib146","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/13524585251316242","article-title":"Characterizing gait in people with multiple sclerosis using digital data from smartphone sensors: a proposed framework","volume":"31","author":"Karatsidis","year":"2025","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.arr.2025.102921_bib147","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1186\/s12889-024-20998-5","article-title":"Motivators and barriers for smoking cessation in people with multiple sclerosis: a qualitative study to inform the design of a tailored intervention","volume":"24","author":"Keller","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.arr.2025.102921_bib148","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12883-020-01882-2","article-title":"Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States","volume":"20","author":"Kern","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib149","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4103\/ijo.IJO_2964_20","article-title":"Evaluation of optical coherence tomography angiography findings in patients with multiple sclerosis","volume":"69","author":"Khader","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.arr.2025.102921_bib150","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/jcm12134274","article-title":"Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges","volume":"12","author":"Khan","year":"2023","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.arr.2025.102921_bib151","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuroscience.2024.04.004","article-title":"Immune system dysregulation in the progression of multiple sclerosis: molecular insights and therapeutic implications","volume":"548","author":"Khan","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2025.102921_bib152","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61876-9","article-title":"AI-based model for automatic identification of multiple sclerosis based on enhanced sea-horse optimizer and MRI scans","volume":"14","author":"Khattap","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106286","article-title":"A real-world data of serum neurofilament light chain in a large cohort of Egyptian multiple sclerosis patients: Hospital-based study","volume":"94","author":"khedr","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib154","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.212.supp.0717.6166","article-title":"Development of a novel long-acting injectable, IVL4002 for modulation of multiple sclerosis: pharmacokinetics and efficacy studies in an experimental autoimmune encephalomyelitis mouse model","volume":"212","author":"Kim","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib155","first-page":"45","article-title":"Comparative analysis of glymphatic system alterations in multiple sclerosis and neuromyelitis optica spectrum disorder using <scp>MRI<\/scp> indices from diffusion tensor imaging","author":"Kim","year":"2024","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.arr.2025.102921_bib156","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cen3.12591","article-title":"Regulatory t cells in multiple sclerosis","volume":"11","author":"Kimura","year":"2020","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.arr.2025.102921_bib157","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1111\/ejn.16300","article-title":"Prognostic relevance of the C-X-C motif chemokine ligand 13 and interleukin-8 in predicting the transition from clinically isolated syndrome to multiple sclerosis","volume":"59","author":"Kl\u00ed\u010dov\u00e1","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2025.102921_bib158","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/acn3.51644","article-title":"Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy","volume":"9","author":"Klistorner","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib159","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WCO.0000000000001262","article-title":"Understanding multiple sclerosis as a disease spectrum: above and below the clinical threshold","volume":"37","author":"Krieger","year":"2024","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/acn3.51187","article-title":"Biosensor vital sign detects multiple sclerosis progression","volume":"8","author":"Krysko","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.tifs.2025.105018","article-title":"Recent advancements of light-emitting diodes in dairy industries","volume":"160","author":"KS","year":"2025","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.arr.2025.102921_bib162","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib163","doi-asserted-by":"crossref","first-page":"569","DOI":"10.5603\/pjnns.102356","article-title":"Disease-modifying therapy in multiple sclerosis: recommendations of multiple sclerosis and neuroimmunology section of polish neurological society","volume":"58","author":"Ku\u0142akowska","year":"2024","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.arr.2025.102921_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105019","article-title":"Risky movement: assessing fall risk in people with multiple sclerosis with wearable sensors and beacon-based smart-home monitoring","volume":"79","author":"Kushner","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105915","article-title":"Neurofilament heavy chain and chitinase 3-like 1 as markers for monitoring therapeutic response in multiple sclerosis","volume":"91","author":"Kusnierova","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123577","article-title":"Ocrelizumab as first-line therapy in highly active relapsing-remitting multiple sclerosis","volume":"475","author":"Kvartskhava","year":"2025","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib167","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231348","article-title":"NF-\u03baB subunits RelA and c-Rel selectively control CD4+ t cell function in multiple sclerosis and cancer","volume":"221","author":"Lalle","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.arr.2025.102921_bib168","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/neurolint12030016","article-title":"Ozanimod to treat relapsing forms of multiple sclerosis: a comprehensive review of disease, drug efficacy and side effects","volume":"12","author":"Lassiter","year":"2020","journal-title":"Neurol. Int"},{"key":"10.1016\/j.arr.2025.102921_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.935382","article-title":"Development of a highly sensitive neurofilament light chain assay on an automated immunoassay platform","volume":"13","author":"Lee","year":"2022","journal-title":"Front Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib170","first-page":"31","article-title":"Sex- and age-related shift of relapse phenotypes in a cohort of relapsing multiple sclerosis patients: post hoc analysis from the <scp>OPERA<\/scp> phase 3 trials","author":"Leon Betancourt","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib171","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68098-z","article-title":"Deciphering the role of protein kinase a in the control of FoxP3 expression in regulatory t cells in health and autoimmunity","volume":"14","author":"Lepore","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib172","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200258","article-title":"Blood neurofilament light in progressive multiple sclerosis","volume":"98","author":"Leppert","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102921_bib173","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Reassessing b cell contributions in multiple sclerosis","volume":"19","author":"Li","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib174","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjaf005","article-title":"Combination therapy dramatically promotes remyelination","volume":"17","author":"Li","year":"2025","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.arr.2025.102921_bib175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12865-025-00735-2","article-title":"Clinical applications and diagnostic research of GFAP and NfL in MS and NMOSD: a meta-analysis","volume":"26","author":"Lin","year":"2025","journal-title":"BMC Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib176","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.835345","article-title":"IFN-\u03b3-Primed hUCMSCs significantly reduced inflammation via the Foxp3\/ROR-\u03b3t\/STAT3 signaling pathway in an animal model of multiple sclerosis","volume":"13","author":"Ling","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib177","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/RLI.0000000000000913","article-title":"Lesion-Specific metabolic alterations in Relapsing-Remitting multiple sclerosis via 7 t magnetic resonance spectroscopic imaging","volume":"58","author":"Lipka","year":"2023","journal-title":"Invest Radio."},{"key":"10.1016\/j.arr.2025.102921_bib178","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1080\/01616412.2021.1949683","article-title":"Calcium-phosphate homeostasis in secondary progressive multiple sclerosis patients during mitoxantrone therapy","volume":"43","author":"Lis","year":"2021","journal-title":"Neurol. Res"},{"key":"10.1016\/j.arr.2025.102921_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102826","article-title":"Disease modifying therapies in relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis","volume":"20","author":"Liu","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.arr.2025.102921_bib180","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.3390\/ijms241612912","article-title":"Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis","volume":"24","author":"L\u00f3pez-Muguruza","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib181","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200251","article-title":"Alterations of Thymus-Derived tregs in multiple sclerosis","volume":"11","author":"Lorenzini","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib182","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00134","article-title":"Suppression of HIV replication by CD8+ regulatory T-Cells in elite controllers","volume":"7","author":"Lu","year":"2016","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib183","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ana.23863","article-title":"Randomized study combining interferon and glatiramer acetate in multiple sclerosis","volume":"73","author":"Lublin","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib184","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12035-022-03060-6","article-title":"CSF CXCL13 and chitinase 3-like-1 levels predict disease course in relapsing multiple sclerosis","volume":"60","author":"Lucchini","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102921_bib185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.21608\/jcmrp.2024.276604.1031","article-title":"Gender difference of serum micro RNA-155 in multiple sclerosis patients","volume":"9","author":"M. Bakkar","year":"2024","journal-title":"J. Curr. Med. Res. Pract."},{"key":"10.1016\/j.arr.2025.102921_bib186","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/acn3.52187","article-title":"Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis","volume":"11","author":"Madill","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib187","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/antiox11061146","article-title":"Neurodegeneration in multiple sclerosis: the role of Nrf2-Dependent pathways","volume":"11","author":"Maldonado","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2025.102921_bib188","article-title":"Surface plasmon resonance imaging (SPRi) in combination with machine learning for microarray analysis of multiple sclerosis biomarkers in whole serum","volume":"10","author":"Malinick","year":"2022","journal-title":"Biosens. Bioelectron. X"},{"key":"10.1016\/j.arr.2025.102921_bib189","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12325-024-03047-w","article-title":"Real-World safety and effectiveness of dimethyl fumarate in patients with MS: results from the ESTEEM phase 4 and PROCLAIM phase 3 studies with a focus on older patients","volume":"42","author":"Mao-Draayer","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.arr.2025.102921_bib190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/cei\/uxae032","article-title":"Dysregulated lipid metabolism networks modulate T-cell function in people with relapsing-remitting multiple sclerosis","volume":"217","author":"Martin-Gutierrez","year":"2024","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib191","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41467-020-20594-2","article-title":"A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis","volume":"12","author":"McKinney","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2025.102921_bib192","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jnnp-2013-305298","article-title":"Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients","volume":"85","author":"Michel","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102921_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105402","article-title":"Prognostic value of cerebrospinal fluid biomarkers in multiple sclerosis: the key role of kappa free light chains and a multivariate predictor for disease progression","volume":"82","author":"Miklu\u0161ov\u00e1","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib194","doi-asserted-by":"crossref","DOI":"10.4081\/ejtm.2024.12993","article-title":"Vitamin d receptor gene polymorphisms in patients with relapsing multiple sclerosis","author":"Milanifard","year":"2024","journal-title":"Eur. J. Transl. Myol."},{"key":"10.1016\/j.arr.2025.102921_bib195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2217\/nmt-2021-0014","article-title":"An updated review of teriflunomide\u2019s use in multiple sclerosis","volume":"11","author":"Miller","year":"2021","journal-title":"Neurodegener. Dis. Manag"},{"key":"10.1016\/j.arr.2025.102921_bib196","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/ene.14680","article-title":"Prognostic value of natural killer cell\/t cell ratios for disease activity in multiple sclerosis","volume":"28","author":"Mimpen","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib197","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.msard.2018.01.020","article-title":"The interplay of multiple sclerosis and menstrual cycle: which one affects the other one?","volume":"21","author":"Mirmosayyeb","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib198","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/ene.15900","article-title":"Cognitive function in primary and secondary progressive multiple sclerosis: a multiparametric magnetic resonance imaging study","volume":"30","author":"Mistri","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib199","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001108","article-title":"B cells in the CNS at postmortem are associated with worse outcome and cell types in multiple sclerosis","volume":"9","author":"Moccia","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib200","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71315-4","article-title":"The presence of oligoclonal bands predicts conversion to multiple sclerosis in isolated myelitis","volume":"14","author":"Monschein","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib201","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2025.102921_bib202","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/13524585211028561","article-title":"A smartphone sensor-based digital outcome assessment of multiple sclerosis","volume":"28","author":"Montalban","year":"2022","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.arr.2025.102921_bib203","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200306","article-title":"Impact of the multiple Sclerosis-Associated genetic variant cd226 Gly307Ser on human CD8 T-Cell functions","volume":"11","author":"Morandi","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib204","first-page":"133","article-title":"Co-supplementation of synbiotics and anti-inflammatory-antioxidant rich diet in patients with progressive forms of multiple sclerosis: a single-center, randomized clinical trial","volume":"17","author":"Moravejolahkami","year":"2024","journal-title":"Med J. Nutr. Metab."},{"key":"10.1016\/j.arr.2025.102921_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103995","article-title":"Use of natalizumab in persons with multiple sclerosis: 2022 update","volume":"65","author":"Morrow","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib206","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1111\/ene.16044","article-title":"Comparative analysis of dimethyl fumarate and teriflunomide in relapsing\u2013remitting multiple sclerosis","volume":"30","author":"M\u00fcller","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib207","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12883-021-02361-y","article-title":"Wearable inertial sensors are highly sensitive in the detection of gait disturbances and fatigue at early stages of multiple sclerosis","volume":"21","author":"M\u00fcller","year":"2021","journal-title":"BMC Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib208","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2174\/0115672050358397250126151707","article-title":"Tauopathy in AD: therapeutic potential of MARK-4","volume":"21","author":"Mumtaz","year":"2024","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.arr.2025.102921_bib209","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s41983-025-01002-2","article-title":"FOXP3 and cholesterol 7\u03b1-hydroxylase variants: unraveling genetic links to multiple sclerosis and neuromyelitis optica","volume":"61","author":"Nassef","year":"2025","journal-title":"Egypt J. Neurol. Psychiatr. Neurosurg."},{"key":"10.1016\/j.arr.2025.102921_bib210","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.3390\/ijms25073803","article-title":"The immunometabolic gene N-Acetylglucosamine kinase is uniquely involved in the heritability of multiple sclerosis severity","volume":"25","author":"Nataf","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib211","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200361","article-title":"Aberrant complement activation is associated with structural brain damage in multiple sclerosis","volume":"12","author":"Oechtering","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib212","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41598-023-49299-4","article-title":"Use of smartphone-based remote assessments of multiple sclerosis in floodlight open, a global, prospective, open-access study","volume":"14","author":"Oh","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib213","doi-asserted-by":"crossref","DOI":"10.1111\/jon.70005","article-title":"High-Field-Blinded assessment of portable Ultra-Low-Field brain MRI for multiple sclerosis","volume":"35","author":"Okar","year":"2025","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.arr.2025.102921_bib214","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s43440-024-00642-0","article-title":"Multiple sclerosis: a narrative overview of current pharmacotherapies and emerging treatment prospects","volume":"76","author":"Olejnik","year":"2024","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib215","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69979-9","article-title":"A preliminary study of the concentration of metallic elements in the blood of patients with multiple sclerosis as measured by ICP-MS","volume":"10","author":"de Oliveira","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib216","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/diagnostics12020230","article-title":"Lesion volume quantification using two convolutional neural networks in MRIs of multiple sclerosis patients","volume":"12","author":"de Oliveira","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.arr.2025.102921_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102834","article-title":"Central vein sign: a diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial","volume":"32","author":"Ontaneda","year":"2021","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.arr.2025.102921_bib218","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40478-023-01598-7","article-title":"Pathological ultrastructural alterations of myelinated axons in normal appearing White matter in progressive multiple sclerosis","volume":"11","author":"Oost","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2025.102921_bib219","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40263-021-00875-0","article-title":"Impact of natural killer (NK) cells on immune reconstitution, and their potential as a biomarker of disease activity, in Alemtuzumab-Treated patients with relapsing remitting multiple sclerosis: an observational study","volume":"36","author":"Palmeri","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arr.2025.102921_bib220","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41598-022-27169-9","article-title":"Potentially toxic elements in the brains of people with multiple sclerosis","volume":"13","author":"Pamphlett","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib221","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/acn3.51473","article-title":"Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study","volume":"8","author":"Paul","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib222","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.immuni.2023.10.016","article-title":"Intestinal epithelial dopamine receptor signaling drives sex-specific disease exacerbation in a mouse model of multiple sclerosis","volume":"56","author":"Peng","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.arr.2025.102921_bib223","first-page":"154","article-title":"The impact of cytomegalovirus infection on natural killer and CD8+ t cell phenotype in multiple sclerosis","volume":"13","author":"Perri","year":"2024","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.arr.2025.102921_bib224","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/joim.13215","article-title":"Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis","volume":"289","author":"Piehl","year":"2021","journal-title":"J. Intern Med"},{"key":"10.1016\/j.arr.2025.102921_bib225","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1007\/s00259-022-05899-2","article-title":"Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET\/MR study","volume":"49","author":"Pitombeira","year":"2022","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.arr.2025.102921_bib226","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/acs.jproteome.2c00460","volume":"22","author":"Pomary","year":"2023","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.arr.2025.102921_bib227","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138519","article-title":"Oleic acid restores suppressive defects in tissue-resident FOXP3 tregs from patients with multiple sclerosis","volume":"131","author":"Pompura","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.arr.2025.102921_bib228","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1007\/s00415-024-12448-4","article-title":"Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression","volume":"271","author":"Portaccio","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib229","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200205","article-title":"Chronic active lesions and larger choroid plexus explain cognition and fatigue in multiple sclerosis","volume":"11","author":"Preziosa","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib230","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70255-z","article-title":"Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years","volume":"10","author":"Pulido-Valdeolivas","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib231","article-title":"Regulatory T-cells in multiple sclerosis are activated by Epstein-Barr virus and produce IL-10","author":"Pulvirenti","year":"2024","journal-title":"Cent. Nerv. Syst."},{"key":"10.1016\/j.arr.2025.102921_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2024.108514","article-title":"Progression predictors of clinically isolated syndrome to multiple sclerosis: a prospective study in China","volume":"245","author":"Qiu","year":"2024","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.arr.2025.102921_bib233","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/biomedicines9121758","article-title":"Combined therapy of vitamin D3-Tolerogenic dendritic cells and Interferon-\u03b2 in a preclinical model of multiple sclerosis","volume":"9","author":"Quirant-S\u00e1nchez","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2025.102921_bib234","doi-asserted-by":"crossref","DOI":"10.18502\/cjn.v19i3.5424","article-title":"A randomized controlled trial investigating the effects of a Mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue","author":"Razeghi-Jahromi","year":"2021","journal-title":"Curr. J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib235","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bpa.12841","article-title":"B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis","volume":"30","author":"Reali","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2025.102921_bib236","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1148\/radiol.2021204426","article-title":"Choroid plexus enlargement in inflammatory multiple sclerosis: 3.0-T MRI and translocator protein PET evaluation","volume":"301","author":"Ricigliano","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.arr.2025.102921_bib237","article-title":"Azathioprine for people with multiple sclerosis","volume":"2024","author":"Ridley","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.arr.2025.102921_bib238","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1080\/09638288.2024.2388259","article-title":"Diet and multiple sclerosis \u2013 development and mixed methods feasibility testing of a comprehensive nutritional information resource (NUTRIMS)","volume":"47","author":"Riemann-Lorenz","year":"2025","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.arr.2025.102921_bib239","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/brain\/awab385","article-title":"The impact of smoking cessation on multiple sclerosis disease progression","volume":"145","author":"Rodgers","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.102921_bib240","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s13760-024-02488-y","article-title":"Relapsing\u2013remitting multiple sclerosis patients exhibit differential natural killer functional subpopulations","volume":"124","author":"Rodrigues Barreto","year":"2024","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.arr.2025.102921_bib241","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.818325","article-title":"Long-Term effects of alemtuzumab on CD4+ lymphocytes in multiple sclerosis patients: a 72-Month Follow-Up","volume":"13","author":"Rolla","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib242","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00996","article-title":"Management of MS patients treated with daclizumab \u2013 a case series of 267 patients","volume":"11","author":"Rommer","year":"2020","journal-title":"Front Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib243","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.794077","article-title":"NK cells and Innate-Like t cells after autologous hematopoietic stem cell transplantation in multiple sclerosis","volume":"12","author":"Ruder","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib244","first-page":"781","article-title":"Oligodendrocytes, BK channels and the preservation of myelin","volume":"10","author":"Rupnik","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.arr.2025.102921_bib245","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16146","article-title":"Efficacy and safety of the implantable, magnetic resonance imaging-compatible StimRouter neuromodulation system in the treatment of refractory lower urinary tract symptoms in multiple sclerosis patients","volume":"31","author":"Sacco","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib246","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/apm.13456","article-title":"Exploring the role of mesenchymal stem cells in modulating immune responses via treg and Th2 cell activation: insights from mouse model of multiple sclerosis","volume":"132","author":"Sadeghnejad","year":"2024","journal-title":"APMIS"},{"key":"10.1016\/j.arr.2025.102921_bib247","article-title":"Dermatologic findings after initiation of fingolimod in patients with multiple sclerosis: a real-world experience of five-year follow-up","volume":"11","author":"Samimi","year":"2025","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.arr.2025.102921_bib248","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102810","article-title":"Increased serum glial fibrillary acidic protein associates with microstructural White matter damage in multiple sclerosis","volume":"50","author":"Saraste","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib249","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1177\/1352458520970103","article-title":"High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients","volume":"27","author":"Schneider-Hohendorf","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.arr.2025.102921_bib250","doi-asserted-by":"crossref","DOI":"10.1177\/11795735241296001","article-title":"Best supportive care for patients with primary progressive multiple sclerosis (PPMS) in Germany prior to ocrelizumab treatment: final results from the RETRO PPMS study","volume":"16","author":"Schreiber","year":"2024","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.arr.2025.102921_bib251","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jns.2015.02.019","article-title":"ATON: results from a phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis","volume":"351","author":"Sergott","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib252","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.2174\/1570159X19666211111123202","article-title":"Changes in john cunningham virus index in multiple sclerosis patients treated with different Disease-Modifying therapies","volume":"20","author":"Sgarlata","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2025.102921_bib253","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12883-021-02483-3","article-title":"Association between multiple sclerosis and dietary patterns based on the traditional concept of food nature: a case-control study in Iran","volume":"21","author":"Sharifi","year":"2021","journal-title":"BMC Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib254","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1093\/brain\/awad218","article-title":"The risk of secondary progressive multiple sclerosis is geographically determined but modifiable","volume":"146","author":"Sharmin","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.102921_bib255","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210262","article-title":"Trojan horse nanocapsule enabled in situ modulation of the phenotypic conversion of Th17 cells to treg cells for the treatment of multiple sclerosis in mice","volume":"35","author":"Shi","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.arr.2025.102921_bib256","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s40199-024-00532-z","article-title":"Glatiramer acetate in situ forming gel, a new approach for multiple sclerosis treatment","volume":"32","author":"Shobeirean","year":"2024","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib257","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106562","article-title":"Choroid plexus enlargement and kappa light chains index reflect distinct pathophysiological processes in multiple sclerosis","volume":"101","author":"Shor","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib258","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105469","article-title":"Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study","volume":"84","author":"S\u0131vac\u0131","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib259","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41564-024-01699-6","article-title":"Multiple sclerosis patient-derived spontaneous b cells have distinct EBV and host gene expression profiles in active disease","volume":"9","author":"Soldan","year":"2024","journal-title":"Nat. Microbiol"},{"key":"10.1016\/j.arr.2025.102921_bib260","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1080\/14737175.2023.2289572","article-title":"An update on combination therapies for multiple sclerosis: where are we now?","volume":"23","author":"Sorensen","year":"2023","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.arr.2025.102921_bib261","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208114","article-title":"Comparative effectiveness of natalizumab, fingolimod, and injectable therapies in Pediatric-Onset multiple sclerosis","volume":"102","author":"Spelman","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102921_bib262","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419892360","article-title":"Safety of long-term intrathecal methotrexate in progressive forms of MS","volume":"12","author":"Stark","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib263","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0305042","article-title":"Pathway analysis of peripheral blood CD8+ t cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma","volume":"19","author":"Stefanovi\u0107","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2025.102921_bib264","first-page":"1082","article-title":"Functional disability and brain MRI volumetry results among multiple sclerosis patients during 5-Year Follow-Up","volume":"59","author":"Strautmane","year":"2023","journal-title":"Med. (B Aires)"},{"key":"10.1016\/j.arr.2025.102921_bib265","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp1720","article-title":"An autoimmune transcriptional circuit drives FOXP3 + regulatory t cell dysfunction","volume":"16","author":"Sumida","year":"2024","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.arr.2025.102921_bib266","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/02699206.2019.1645885","article-title":"Changes in temporal features of speech in secondary progressive multiple sclerosis (SPMS) \u2013 case studies","volume":"34","author":"Svindt","year":"2020","journal-title":"Clin. Linguist Phon."},{"key":"10.1016\/j.arr.2025.102921_bib267","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105853","article-title":"Assessing clinical utility of machine learning and artificial intelligence approaches to analyze speech recordings in multiple sclerosis: a pilot study","volume":"148","author":"Svoboda","year":"2022","journal-title":"Comput. Biol. Med"},{"key":"10.1016\/j.arr.2025.102921_bib268","first-page":"101","article-title":"Expression of <scp>STAT<\/scp> - and T-cell-related genes in women with first-line treatment of relapsing-remitting multiple sclerosis","author":"Szewczak","year":"2025","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib269","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1007\/s10072-023-06764-2","article-title":"Chitinase-3-like 1-protein in CSF: a novel biomarker for progression in patients with multiple sclerosis","volume":"44","author":"Talaat","year":"2023","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2025.102921_bib270","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104513","article-title":"Effect of smoking on disease activity in multiple sclerosis patients treated with dimethyl fumarate or fingolimod","volume":"70","author":"Tanaka","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib271","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109797","article-title":"Decreased frequency of regulatory t cells and level of helios gene expression in secondary progressive multiple sclerosis patients: evidence about the development of multiple sclerosis","volume":"116","author":"Tarighi","year":"2023","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.arr.2025.102921_bib272","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.766","article-title":"Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of treg and Th2 cells","volume":"11","author":"Tavaf","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.arr.2025.102921_bib273","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75290-8","article-title":"The combination of CSF neurofilament light chain and glial fibrillary acidic protein improves the prediction of long-term confirmed disability worsening in multiple sclerosis","volume":"14","author":"Thebault","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib274","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.2025.1604","article-title":"High-Dose vitamin d in clinically isolated syndrome typical of multiple sclerosis","volume":"333","author":"Thouvenot","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2025.102921_bib275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.730342","article-title":"Teriflunomide treatment of multiple sclerosis selectively modulates CD8 memory t cells","volume":"12","author":"Tilly","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib276","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105437","article-title":"The glymphatic system as a potential biomarker and therapeutic target in secondary progressive multiple sclerosis","volume":"83","author":"Tomizawa","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib277","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1177\/13524585211003020","article-title":"A randomized study of natalizumab dosing regimens for relapsing\u2013remitting multiple sclerosis","volume":"27","author":"Trojano","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.arr.2025.102921_bib278","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-04741-7","article-title":"Increased burden of rare variants in GWAS associated genes in familial multiple sclerosis","volume":"15","author":"Turk","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib279","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3892\/etm.2023.12048","article-title":"Early metabolic alterations in the normal-appearing grey and White matter of patients with clinically isolated syndrome suggestive of multiple sclerosis: a proton MR spectroscopic study","volume":"26","author":"Tzanetakos","year":"2023","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.arr.2025.102921_bib280","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/glia.24297","article-title":"Characterizing microglial gene expression in a model of secondary progressive multiple sclerosis","volume":"71","author":"Vainchtein","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.arr.2025.102921_bib281","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/ana.26061","article-title":"Genetic variation in <scp> WNT9B <\/scp> increases relapse hazard in multiple sclerosis","volume":"89","author":"Vandebergh","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib282","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2024.110803","article-title":"Clinical laboratory test utilization of CSF oligoclonal bands and IgG index in a tertiary pediatric hospital","author":"Vanderschelden","year":"2024","journal-title":"Clin. Biochem 131132"},{"key":"10.1016\/j.arr.2025.102921_bib283","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1360219","article-title":"Human regulatory memory b cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis","volume":"15","author":"Varghese","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib284","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11882-023-01102-0","article-title":"Multiple sclerosis pathogenesis and updates in targeted therapeutic approaches","volume":"23","author":"Vasileiou","year":"2023","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.arr.2025.102921_bib285","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/biology11030440","article-title":"Endocannabinoid modulation in neurodegenerative diseases: in pursuit of certainty","volume":"11","author":"Vasincu","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.arr.2025.102921_bib286","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77029-7","article-title":"Intrathecal kappa free light chains as markers for multiple sclerosis","volume":"10","author":"Vecchio","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib287","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-88448-5","article-title":"Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells","volume":"11","author":"Verma","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102921_bib288","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/03007995.2020.1865888","article-title":"Efficacy of cladribine tablets in high disease activity patients with relapsing multiple sclerosis: post hoc analysis of subgroups with and without prior disease-modifying drug treatment","volume":"37","author":"Vermersch","year":"2021","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.arr.2025.102921_bib289","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1016\/j.cell.2023.11.015","article-title":"Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis","volume":"186","author":"Vietzen","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.arr.2025.102921_bib290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40273-021-01081-y","article-title":"The potential Cost-Effectiveness of a Cell-Based bioelectronic implantable device delivering Interferon-\u03b21a therapy versus injectable Interferon-\u03b21a treatment in Relapsing\u2013Remitting multiple sclerosis","volume":"40","author":"Visser","year":"2022","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.arr.2025.102921_bib291","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166324","article-title":"Myelin-associated glycoprotein activation triggers glutamate uptake by oligodendrocytes in vitro and contributes to ameliorate glutamate-mediated toxicity in vivo","volume":"1868","author":"Vivinetto","year":"2022","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.arr.2025.102921_bib292","first-page":"86","article-title":"Clinical efficacy of laquinimod 0.6 mg once daily in the treatment of worsening Relapsing-Remitting multiple sclerosis (Baseline EDSS >3) (P3.051)","author":"Vollmer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102921_bib293","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00702-023-02737-z","article-title":"Obsessive\u2013compulsive symptoms and brain lesions compatible with multiple sclerosis","volume":"131","author":"von Zedtwitz","year":"2024","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2025.102921_bib294","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00031","article-title":"CD28\u2212 and CD28lowCD8+ regulatory t cells: of mice and men","volume":"8","author":"Vuddamalay","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib295","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106465","article-title":"Radiomics-based analysis of choroid plexus abnormalities in neuromyelitis optica spectrum disorders and multiple sclerosis and their clinical implications","volume":"99","author":"Wang","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102921_bib296","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchp.2023.100415","article-title":"Relationship between physical activity and coping with stress in people with multiple sclerosis: a moderated mediation model with self-efficacy and disability level as variables","volume":"24","author":"Wilski","year":"2024","journal-title":"Int. J. Clin. Health Psychol."},{"key":"10.1016\/j.arr.2025.102921_bib297","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13293-024-00618-y","article-title":"Sex- and species-specific contribution of CD99 to t cell costimulation during multiple sclerosis","volume":"15","author":"Winschel","year":"2024","journal-title":"Biol. Sex. Differ."},{"key":"10.1016\/j.arr.2025.102921_bib298","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/brain\/awad031","article-title":"Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic","volume":"146","author":"Wong","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.102921_bib299","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41583-024-00823-z","article-title":"The neuropathobiology of multiple sclerosis","volume":"25","author":"Woo","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2025.102921_bib300","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/jnnp-2022-330848","article-title":"Influence of oral tobacco versus smoking on multiple sclerosis disease activity and progression","volume":"94","author":"Wu","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102921_bib301","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200289","article-title":"Association between alcohol consumption and disability accumulation in multiple sclerosis","volume":"11","author":"Wu","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib302","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16269","article-title":"Association between sun exposure habits and disease progression in multiple sclerosis","volume":"31","author":"Wu","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib303","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200334","article-title":"Obesity affects disease activity and progression, cognitive functioning, and quality of life in people with multiple sclerosis","volume":"12","author":"Wu","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102921_bib304","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103240","article-title":"Peroxynitrite reduces treg cell expansion and function by mediating IL-2R nitration and aggravates multiple sclerosis pathogenesis","volume":"75","author":"Wu","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.arr.2025.102921_bib305","article-title":"Disease-modifying therapy in progressive multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials","volume":"15","author":"Wu","year":"2024","journal-title":"Front Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib306","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/acn3.51621","article-title":"Evaluating brain damage in multiple sclerosis with simultaneous <scp>multi-angular-relaxometry<\/scp> of tissue","volume":"9","author":"Xiang","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib307","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106500","article-title":"Oxidative stress activity of fingolimod in multiple sclerosis","volume":"202","author":"Yevgi","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.arr.2025.102921_bib308","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/diagnostics13040596","article-title":"Retinal blood vessel analysis using optical coherence tomography (OCT) in multiple sclerosis","volume":"13","author":"Young","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.arr.2025.102921_bib309","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.212.supp.1002.5243","article-title":"Identifying the role of antigen-specific resident memory CD4 t cells in maintaining disease during experimental autoimmune encephalomyelitis a murine model of multiple sclerosis","volume":"212","author":"Yuzefpolskiy","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.arr.2025.102921_bib310","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1164001","article-title":"Validity of an inertial sensor-based system for the assessment of spatio-temporal parameters in people with multiple sclerosis","volume":"14","author":"Zahn","year":"2023","journal-title":"Front Neurol."},{"key":"10.1016\/j.arr.2025.102921_bib311","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41591-024-02938-3","article-title":"An autoantibody signature predictive for multiple sclerosis","volume":"30","author":"Zamecnik","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2025.102921_bib312","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1007\/s12035-023-03655-7","article-title":"Teriflunomide promotes Blood\u2013Brain barrier integrity by upregulating Claudin-1 via the Wnt\/\u03b2-catenin signaling pathway in multiple sclerosis","volume":"61","author":"Zhao","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102921_bib313","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000527720","article-title":"Radiological disease activity in secondary progressive multiple sclerosis","volume":"86","author":"Zohar","year":"2023","journal-title":"Eur. Neurol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725002673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725002673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:28:18Z","timestamp":1773304098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725002673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":313,"alternative-id":["S1568163725002673"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.102921","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From pathogenesis to precision medicine: Targeting immune imbalance in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.102921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102921"}}